Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $24.3100 (-1.18%) ($24.1700 - $25.4500) on Tue. May. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.29% (three month average) | RSI | 54 | Latest Price | $24.3100(-1.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.2% a day on average for past five trading days. | Weekly Trend | HALO advances 0.6% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(50%) IWM(46%) IWC(44%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -2.145% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-2%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.145% (StdDev 4.29%) | Hourly BBV | 0 () | Intraday Trend | -3.1% | | | |
|
5 Day Moving Average | $24.17(0.58%) | 10 Day Moving Average | $24.08(0.96%) | 20 Day Moving Average | $23.83(2.01%) | To recent high | -2.1% | To recent low | 74.9% | Market Cap | $3.322b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |